Product Wiki · Recalls · EU Safety Gate (RAPEX)

Flip flops — recall A12/01876/24

EU Safety Gate (RAPEX) · Finland · 2024-07-19 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/01876/24
Date of alert
2024-07-19
Country / jurisdiction
Finland
Risk level
Serious risk
Risk type
Chemical
Brand
Day Wear
Product category
Clothing, textiles and fashion items
Product type
Flip flops
Barcode (EAN/GTIN)
6438159383851
Reported risk: Hihnojen muovimateriaali sisältää liiallisen määrän dibutyyliftalaattia (DBP) (mitattu arvo: 35 painoprosenttia). DBP voi vahingoittaa terveyttä aiheuttamalla mahdollisia vaurioita lisääntymiselimille. Tuote ei täytä REACH-asetuksen vaatimuksia.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Importer
Category of measure
Import rejected at border
Date of entry into force
13/06/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Risk Description (original English): The plastic material of the straps contains an excessive amount of dibutyl phthalate (DBP) (measured value: 35% by weight). DBP may harm the health by causing possible damage to the reproductive system.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10013699

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.